Australian Phase 2b Study to Assess Effect of Dose Interval on Spikogen Covid-19 Vaccine

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
A study to assess the effect of varying the time interval between doses on the immunogenicity of an adjuvanted recombinant spike protein Covid-19 vaccine (Spikogen/Covax-19)
Epistemonikos ID: fa23483ce3c912a478dfd78989cbb97be5f858f2
First added on: Dec 09, 2021